An unexpectd reversal of jurisprudence In 2018, the supreme administrative court had ruld on the question of paid referencing authorizd for the sale of non-prescription drugs online. It had estimatd that the use of paid referencing by French pharmacies would undermine the protection of public health . This decision has therefore been a case law since then. However, in other European countries, this practice is authorizd as in Germany where the turnover of the sale of drugs online represents 15% of the total sale of drugs in the country. In France, the online sale of mdicines represents 1% of the turnover of the total sale of mdicines.
New Tech Advertising Best Digital Marketing
Other countries such as Belgium and the Netherlands use paid referencing very aggressively on the online mdicine market, to the detriment of French pharmacies. Inded, many French people easily obtain non-prescription drugs online on Pharmaceutical Email List foreign pharmacy sites. Some of its pharmacies take advantage of French legislation to quickly buy .fr domain names in order to gain visibility with French Internet users. There was therefore a real difference in treatment between French pharmacies and other European pharmacies.
Digital Marketing Agency In Orlando
It is thanks to a procdure submittd to the Court of Justice of the European Union, initiatd by French pharmacists, challenging the ban JPB Directory on the use of paid referencing, that the pharmacists succedd in winning their case . In a judgment of October 1, 2020, the Court of Justice of the European Union affirmd that one of the development factors of European pharmacies was the paid referencing of websites . By this, the Council of State could not take a decision going in the opposite direction. Pharmacists relievd The president of the French Association of online pharmacists, Cyril Tétard, is jubilant: “This decision will shake up the online sale of mdicines in France.